{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:49:32Z","timestamp":1789940972304,"version":"4.0.1"},"reference-count":48,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T00:00:00Z","timestamp":1423008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001282","name":"Ovarian Cancer Research Fund","doi-asserted-by":"publisher","award":["Liz Tilberis Award"],"award-info":[{"award-number":["Liz Tilberis Award"]}],"id":[{"id":"10.13039\/100001282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA160917"],"award-info":[{"award-number":["CA160917"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Epithelial ovarian carcinoma is the deadliest gynecologic malignancy. One reason underlying treatment failure is resistance to paclitaxel. Expression of the microtubule associated protein tau has recently been proposed as a predictor of response to paclitaxel in ovarian carcinoma patients. Expression of tau was probed using immunohistochemistry  in 312 specimens of primary, and 40 specimens of metastatic, ovarian carcinoma. Serous epithelial ovarian carcinoma cell line models were used to determine the expression of tau by Western blot and immunofluorescence staining. Subcellular fractionation and Western blot were employed to examine nuclear and cytoplasmic localization of tau. Gene silencing and clonogenic assays were used to evaluate paclitaxel response. Tau was expressed in 44% of all tested cases. Among the primary serous epithelial ovarian carcinoma cases, 46% were tau-positive. Among the metastatic serous epithelial ovarian carcinomas, 63% were  tau-positive. Cell culture experiments demonstrated that tau was expressed in multiple isoforms. Three-dimensional collagen I matrix culture conditions resulted in up-regulation of tau protein. Silencing of tau with specific siRNAs in a combination with three-dimensional culture conditions led to a significant decrease of the clonogenic ability of cells treated with paclitaxel. The data suggest that reduction of tau expression may sensitize ovarian carcinoma to the paclitaxel treatment.<\/jats:p>","DOI":"10.3390\/ijms16023419","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T08:25:00Z","timestamp":1423038300000},"page":"3419-3433","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Three-Dimensional Collagen Type I Matrix Up-Regulates Nuclear Isoforms of the Microtubule Associated  Protein Tau Implicated in Resistance to Paclitaxel  Therapy in Ovarian Carcinoma"],"prefix":"10.3390","volume":"16","author":[{"given":"Hilal","family":"Gurler","sequence":"first","affiliation":[{"name":"Department of Biopharmaceutical Sciences, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutical Sciences, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Illinois at Chicago, 840 South Wood Street,  Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Kajdacsy-Balla","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Illinois at Chicago, 840 South Wood Street,  Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Barbolina","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutical Sciences, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,2,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1158\/0008-5472.CAN-11-3911","article-title":"The changing view of high-grade serous ovarian cancer","volume":"72","author":"Berns","year":"2012","journal-title":"Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2559.2011.04167.x","article-title":"Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum)","volume":"61","author":"Delair","year":"2012","journal-title":"Histopathology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","article-title":"Ovarian carcinomas: Five distinct diseases with different origins, genetic alterations, and clinicopathological features","volume":"460","author":"Prat","year":"2012","journal-title":"Virchows Arch."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrclinonc.2010.120","article-title":"Weekly paclitaxel in the treatment of recurrent ovarian cancer","volume":"7","author":"Baird","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.2174\/138161212802002634","article-title":"Review of dose-intense platinum and\/or paclitaxel containing chemotherapy in advanced and recurrent epithelial ovarian cancer","volume":"18","author":"Boere","year":"2012","journal-title":"Curr. Pharm Des."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/GRF.0b013e31824b45da","article-title":"First-line chemotherapy in epithelial ovarian cancer","volume":"55","author":"Bookman","year":"2012","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ygyno.2013.05.029","article-title":"Current standards of care for chemotherapy of optimally cytoreduced advanced epithelial ovarian cancer","volume":"131","author":"Markman","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_9","first-page":"2069","article-title":"Advanced epithelial ovarian cancer: From standard chemotherapy to promising molecular pathway targets\u2014Where are we now?","volume":"34","author":"Syrios","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1172\/JCI119642","article-title":"Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes","volume":"100","author":"Kavallaris","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1756-9966-32-25","article-title":"Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel\/platinum first-line chemotherapy","volume":"32","author":"Smoter","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1242\/jcs.14.3.523","article-title":"Arrangement of subunits in flagellar microtubules","volume":"14","author":"Amos","year":"1974","journal-title":"J. Cell Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1016\/S1074-5521(99)89002-4","article-title":"How Taxol stabilises microtubule structure","volume":"6","author":"Amos","year":"1999","journal-title":"Chem. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/emboj\/cdg001","article-title":"Repeat motifs of tau bind to the insides of microtubules in the absence of Taxol","volume":"22","author":"Kar","year":"2003","journal-title":"EMBO J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/alzrt259","article-title":"Acetylation: A new key to unlock tau\u2019s role in neurodegeneration","volume":"6","author":"Cook","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tcb.2014.07.005","article-title":"Connecting the dots between tau dysfunction and neurodegeneration","volume":"25","author":"Frost","year":"2014","journal-title":"Trends Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer\u02bcs disease","volume":"82","author":"Hyman","year":"2014","journal-title":"Neuron"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.tins.2014.08.004","article-title":"Lost after translation: Missorting of Tau protein and consequences for Alzheimer disease","volume":"37","author":"Zempel","year":"2014","journal-title":"Trends Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1002\/j.1460-2075.1990.tb07870.x","article-title":"Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization","volume":"9","author":"Goedert","year":"1990","journal-title":"EMBO J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"19855","DOI":"10.1074\/jbc.R114.549295","article-title":"Prion-like properties of Tau protein: The importance of extracellular tau as a therapeutic target","volume":"289","author":"Holmes","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fncel.2014.00113","article-title":"The role of extracellular Tau in the spreading of neurofibrillary pathology","volume":"8","author":"Medina","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1007\/s00018-014-1610-7","article-title":"Transport and diffusion of tau protein in neurons","volume":"71","author":"Scholz","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1242\/jcs.02907","article-title":"Tau protein binds to pericentromeric DNA: A putative role for nuclear tau in nucleolar organization","volume":"119","author":"Sjoberg","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1097-0169(1997)38:1<100::AID-CM9>3.0.CO;2-C","article-title":"Nucleolar localization of the microtubule-associated protein tau in neuroblastomas using sense and anti-sense transfection strategies","volume":"38","author":"Thurston","year":"1997","journal-title":"Cell Motil. Cytoskeleton"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JAD-2010-091279","article-title":"Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors","volume":"21","author":"Wang","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1074\/jbc.M110.199976","article-title":"Nuclear tau, a key player in neuronal DNA protection","volume":"286","author":"Sultan","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00280-011-1696-7","article-title":"The role of tau protein in resistance to paclitaxel","volume":"68","author":"Smoter","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4161\/cc.4.9.2038","article-title":"Microtubule associated protein (MAP)-tau: A novel mediator of paclitaxel sensitivity in vitro and in vivo","volume":"4","author":"Wagner","year":"2005","journal-title":"Cell Cycle"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1158\/1078-0432.CCR-06-2078","article-title":"Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer","volume":"13","author":"Andre","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1073\/pnas.0408974102","article-title":"Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer","volume":"102","author":"Rouzier","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/jjco\/hyp184","article-title":"Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin","volume":"40","author":"Shao","year":"2010","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00280-008-0877-5","article-title":"Tau expression and efficacy of paclitaxel treatment in metastatic breast cancer","volume":"64","author":"Tanaka","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s12032-014-0950-3","article-title":"The relationships between the chemosensitivity of human gastric cancer to paclitaxel and the expressions of class III \u03b2-tubulin, MAPT, and survivin","volume":"31","author":"He","year":"2014","journal-title":"Med. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/sj.bjc.6603182","article-title":"Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment","volume":"94","author":"Mimori","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12253-012-9598-5","article-title":"Relationship between gastric cancer tau protein expression and paclitaxel sensitivity","volume":"19","author":"Wang","year":"2013","journal-title":"Pathol. Oncol. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3892\/ijo.2014.2311","article-title":"Resistance to first line platinum paclitaxel chemotherapy in serous epithelial ovarian cancer: The prediction value of ERCC1 and tau expression","volume":"44","author":"Steffensen","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/labinvest.2008.25","article-title":"Motility-related actinin \u03b1-4 is associated with advanced and metastatic ovarian carcinoma","volume":"88","author":"Barbolina","year":"2008","journal-title":"Lab. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1074\/jbc.M608428200","article-title":"Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression","volume":"282","author":"Barbolina","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ijc.24347","article-title":"Down-regulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion","volume":"125","author":"Barbolina","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/cncr.23341","article-title":"Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion","volume":"112","author":"Barbolina","year":"2008","journal-title":"Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/1541-7786.MCR-09-0463","article-title":"Microenvironmental regulation of chemokine (C-X-C-motif) receptor 4 in ovarian carcinoma","volume":"8","author":"Barbolina","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1074\/jbc.M112.431411","article-title":"Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein","volume":"288","author":"Barbolina","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Buee","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1541-7786.MCR-11-0256","article-title":"Fractalkine receptor CX3CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells","volume":"10","author":"Kim","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1158\/1541-7786.MCR-12-0361","article-title":"The lymphotactin receptor is expressed in epithelial ovarian carcinoma and contributes to cell migration and proliferation","volume":"10","author":"Kim","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"ref_48","first-page":"3545","article-title":"Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer","volume":"50","author":"McClelland","year":"1990","journal-title":"Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/2\/3419\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:42:19Z","timestamp":1760215339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/2\/3419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,4]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2]]}},"alternative-id":["ijms16023419"],"URL":"https:\/\/doi.org\/10.3390\/ijms16023419","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,4]]}}}